These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12029544)

  • 1. Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction.
    Bax JJ; Fath-Ordoubadi F; Boersma E; Wijns W; Camici PG
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):721-7. PubMed ID: 12029544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction.
    Gerber BL; Melin JA; Bol A; Labar D; Cogneau M; Michel C; Vanoverschelde JL
    J Nucl Med; 1998 Oct; 39(10):1655-62. PubMed ID: 9776263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
    Kofoed KF; Carstensen S; Hove JD; Freiberg J; Bangsgaard R; Holm S; Rabøl A; Hesse B; Arendrup H; Kelbaek H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):991-8. PubMed ID: 12173011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.
    Hernandez-Pampaloni M; Bax JJ; Morita K; Dutka DP; Camici PG
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):314-21. PubMed ID: 15791441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study.
    Bondarenko O; Knaapen P; Beek AM; Boellaard R; Lammertsma AA; van Rossum AC
    Nucl Med Commun; 2011 Dec; 32(12):1169-73. PubMed ID: 22045477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
    Schinkel AF; Poldermans D; Rizzello V; van Domburg RT; Valkema R; Elhendy A; Biagini E; Krenning EP; Simoons ML; Bax JJ
    J Nucl Med; 2006 Jan; 47(1):68-73. PubMed ID: 16391189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction.
    Itoh H; Namura M; Seki H; Asai T; Tsuchiya T; Uenishi H; Fujii H; Fujita S; Tanabe Y; Ito J; Shimizu M; Mabuchi H
    Circ J; 2002 Apr; 66(4):341-4. PubMed ID: 11954946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.
    de Silva R; Yamamoto Y; Rhodes CG; Iida H; Nihoyannopoulos P; Davies GJ; Lammertsma AA; Jones T; Maseri A
    Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
    Fath-Ordoubadi F; Pagano D; Marinho NV; Keogh BE; Bonser RS; Camici PG
    Am J Cardiol; 1998 Jul; 82(1):26-31. PubMed ID: 9671004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
    J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Rijnierse MT; Allaart CP; de Haan S; Harms HJ; Huisman MC; Beek AM; Lammertsma AA; van Rossum AC; Knaapen P
    Heart; 2016 Jun; 102(11):832-40. PubMed ID: 26843532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction.
    Knuuti J; Schelbert HR; Bax JJ
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1257-66. PubMed ID: 12192570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation.
    Iida H; Takahashi A; Tamura Y; Ono Y; Lammertsma AA
    J Nucl Med; 1995 Jan; 36(1):78-85. PubMed ID: 7799088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT) and metabolism (F-18-FDG-PET)].
    Schäfer WM; Nowak B; Kaiser HJ; Block S; Koch KC; vom Dahl J; Büll U
    Nuklearmedizin; 2001 Oct; 40(5):164-71. PubMed ID: 11727629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
    Merlet P; Mazoyer B; Hittinger L; Valette H; Saal JP; Bendriem B; Crozatier B; Castaigne A; Syrota A; Randé JL
    J Nucl Med; 1993 Nov; 34(11):1899-904. PubMed ID: 8229231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.